While X4 Pharmaceuticals, Inc. (X4 Pharma) provides financial support for this program, tests and services are performed by independent third parties. Healthcare professionals must confirm that patients meet certain criteria to use the program. X4 Pharma receives de-identified patient data from this program, but at no time does X4 Pharma receive patient identifiable information. X4 Pharma receives contact information for healthcare providers who use this program. Genetic testing is available in the US and Canada only with the potential for expansion into other countries where third party genetic testing is permitted by local rules and regulations. Healthcare professionals who use this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use, or support any X4 Pharma product.
1. Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017;3:17032.